Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001235802-11-000143)

Filing Details

Accession Number:: 0001235802-11-000143
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-08-12 12:10:36
Reporting Period:: 2011-08-12

Filing Date:: 2011-08-12
Accepted Time:: 2011-08-12 12:10:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1023024	Biosante Pharmaceuticals Inc	BPAX	Biological Products, (No Disgnostic Substances) (2836)	582301143

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1013724	J Ross Mangano	C/O Biosante Pharmaceuticals, Inc. 111 Barclay Boulevard Lincolnshire IL 60069		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-12	25,000	$2.40	73,333	No	4	P	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,929,661	Indirect	By JO & Co.
Common Stock	30,000	Indirect	See footnote
Common Stock	33,333	Indirect	By Trust
Common Stock	33,333	Indirect	By Trust
Common Stock	100,000	Indirect	See footnote
Common Stock	165,756	Direct

Footnotes

Shares are held indirectly by Mr. Mangano in various trusts of which Mr. Mangano is the trustee
Shares are held by Oliver & Co., of which Mr. Mangano is a trustee.
Shares are indirectly held by Mr. Mangano as an investment advisor on behalf of an individual.